Back to News
Market Impact: 0.1
Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH?
Source: Nasdaq
Healthcare & BiotechCompany Fundamentals
Fidelity MSCI Health Care Index ETF charges a 0.08% expense ratio, 27bps below the 0.35% fee for State Street's SPDR S&P Pharmaceuticals ETF. The lower-cost structure may improve Fidelity's relative appeal for healthcare-sector ETF investors, but the item provides no performance, asset-flow, or broader market implications.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
MSCI0.15
STT-0.20
More News
- Here’s the ‘core economic flaw’ in the AI bull case as stock and bond trades unravel, according to a top economist
- Biotech stocks are surging. How investors can play the new drug innovation boom
- Braskem creditors, shareholders near deal on $11bn debt restructuring
- Instacart reportedly discussed selling itself with DoorDash and Uber
- Nvidia's role as AI financier faces first big test as neoclouds take market hit
- Trump set to announce plan by Audi to build a U.S. factory in Georgia, source says